BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21729769)

  • 21. Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions.
    Arias-Pulido H; Peyton CL; Torrez-Martínez N; Anderson DN; Wheeler CM
    Virology; 2005 Jul; 338(1):22-34. PubMed ID: 15936050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phylogeny and In Silico Structure Analysis of Major Capsid Protein (L1) Human Papillomavirus 45 from Indonesian Isolates.
    Pradini GW; Sahiratmadja E; Suhandono S; Sudigdoadi S; Yusuf M; Firdaus ARR; Susanto H
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2517-2523. PubMed ID: 32986347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phylogeny and polymorphism in the long control region, E6, and L1 of human papillomavirus types 53, 56, and 66 in central Brazil.
    Wyant PS; Cerqueira DM; Moraes DS; Leite JP; Martins CR; de Macedo Brígido M; Raiol T
    Int J Gynecol Cancer; 2011 Feb; 21(2):222-9. PubMed ID: 21270605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polymorphisms of human papillomavirus type 81 L1 gene in patients with cervical lesions in Guangdong].
    Zeng L; Yu SY; Hu ZH; Zhang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2210-2. PubMed ID: 19114360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-vaccination with adeno-associated virus vectors encoding human papillomavirus 16 L1 proteins and adenovirus encoding murine GM-CSF can elicit strong and prolonged neutralizing antibody.
    Liu DW; Chang JL; Tsao YP; Huang CW; Kuo SW; Chen SL
    Int J Cancer; 2005 Jan; 113(1):93-100. PubMed ID: 15386434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic diversity of HPV-16 E6, E7, and L1 genes in women with cervical lesions in Liaoning Province, China.
    Sun Z; Ren G; Cui X; Zhou W; Liu C; Ruan Q
    Int J Gynecol Cancer; 2011 Apr; 21(3):551-8. PubMed ID: 21436703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
    Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
    J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variant lineages of human papillomavirus type 18 in Northeast China populations characterized by sequence analysis of E6, E7, and L1 regions.
    Sun Z; Liu J; Wang G; Zhou W; Liu C; Ruan Q
    Int J Gynecol Cancer; 2012 Jul; 22(6):930-6. PubMed ID: 22622951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detecting Human Papillomavirus Type 16 in Cervical Cancer Patients with Molecular Variation of Gene L1 in Riau Province Indonesia.
    Savira M; S D; Putra AE; Yusrawati Y; Lipoeto NI
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):87-92. PubMed ID: 35092375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of human papillomavirus type 16 and its genetic variants with cervical lesion in Korea.
    Park JS; Shin S; Kim EC; Kim JE; Kim YB; Oh S; Roh EY; Yoon JH
    APMIS; 2016 Nov; 124(11):950-957. PubMed ID: 27546189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron Microscopy.
    Guan J; Bywaters SM; Brendle SA; Lee H; Ashley RE; Christensen ND; Hafenstein S
    J Virol; 2015 Dec; 89(23):12108-17. PubMed ID: 26401038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular variants of HPV-16 associated with cervical cancer in Indian population.
    Pillai MR; Hariharan R; Babu JM; Lakshmi S; Chiplunkar SV; Patkar M; Tongaonkar H; Dinshaw K; Jayshree RS; Reddy BK; Siddiqui M; Roychoudury S; Saha B; Abraham P; Gnanamony M; Peedicayil A; Subhashini J; Ram TS; Dey B; Sharma C; Jain SK; Singh N
    Int J Cancer; 2009 Jul; 125(1):91-103. PubMed ID: 19358280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies.
    Carpentier GS; Fleury MJ; Touzé A; Sadeyen JR; Tourne S; Sizaret PY; Coursaget P
    J Med Virol; 2005 Dec; 77(4):558-65. PubMed ID: 16254978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variability in minor capsid protein (L2 gene) of human papillomavirus type 16 among Indian women.
    Mane A; Limaye S; Patil L; Kulkarni-Kale U
    Med Microbiol Immunol; 2022 Jun; 211(2-3):153-160. PubMed ID: 35552511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mutations of human papillomavirus (HPV) 16 type L1 genes from cervical carcinoma biopsies in southern Xinjiang Uygur women].
    Ma ZH; Zhang FC; Mei XD; Ma CL; Liu KJ
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):987-91. PubMed ID: 15312531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing the secondary structure of human papillomavirus type 16 L1 mRNA enhances L1 protein expression in Saccharomyces cerevisiae.
    Kim HJ; Lee SJ; Kim HJ
    J Biotechnol; 2010 Oct; 150(1):31-6. PubMed ID: 20696192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphism of the capsid L1 gene of human papillomavirus types 31, 33, and 35.
    Cornut G; Gagnon S; Hankins C; Money D; Pourreaux K; Franco EL; Coutlée F;
    J Med Virol; 2010 Jul; 82(7):1168-78. PubMed ID: 20513080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological study in Tunisian cervical cancer patients.
    Achour M; Kochbati L; Zeghal D; Kahla S; Maalej M; Zouari F; Oueslati R
    Pathol Biol (Paris); 2009 Jul; 57(5):415-9. PubMed ID: 18586408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccine.
    Gu Y; Wei M; Wang D; Li Z; Xie M; Pan H; Wu T; Zhang J; Li S; Xia N
    Vaccine; 2017 Aug; 35(35 Pt B):4637-4645. PubMed ID: 28736197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.